IDEAYA Biosciences, Inc. (IDYA)
NASDAQ: IDYA · Real-Time Price · USD
29.15
-0.32 (-1.09%)
Jun 1, 2026, 1:44 PM EDT - Market open
IDEAYA Biosciences Market Cap
IDEAYA Biosciences has a market cap or net worth of $2.56 billion as of June 1, 2026. Its market cap has increased by 71.01% in one year.
Market Cap
2.56B
Enterprise Value
1.60B
1-Year Change
71.01%
Ranking
Category
Stock Price
$29.15
Market Cap Chart
Since May 23, 2019, IDEAYA Biosciences's market cap has increased from $215.57M to $2.56B, an increase of 1,088.10%. That is a compound annual growth rate of 42.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 2.59B | -14.56% |
| Dec 31, 2025 | 3.03B | 36.44% |
| Dec 31, 2024 | 2.22B | -3.15% |
| Dec 29, 2023 | 2.29B | 162.34% |
| Dec 30, 2022 | 874.22M | -3.92% |
| Dec 31, 2021 | 909.90M | 123.69% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 23, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Structure Therapeutics | 2.80B |
| Alumis | 2.75B |
| Arcutis Biotherapeutics | 2.68B |
| Disc Medicine | 2.66B |
| Definium Therapeutics | 2.64B |
| Mineralys Therapeutics | 2.60B |
| Tarsus Pharmaceuticals | 2.56B |
| Vera Therapeutics | 2.55B |